Research Paper Volume 16, Issue 5 pp 4204—4223
The crucial role of age and site in incidence and prognosis of female neuroendocrine neoplasms in the United States: a population-based study from 2000 to 2018
Figure 2. Incidence of female neuroendocrine neoplasms (fNENs) patients with different sites in various age groups. The incidence of fNENs by site in patients younger than 30 years old (A), between 30-39 years old (B), between 40-49 years old (C), between 50-59 years old (D), between 60-69 years old (E), between 70-79 years old (F) and over 80 years old (G).